# FDA 483 - Cassius I. O. Chaar, M.D. - August 15, 2025

Source: https://www.globalkeysolutions.net/records/483/cassius-i-o-chaar-md/6780a783-be69-481a-a6d5-bfacfc98196f

> FDA 483 for Cassius I. O. Chaar, M.D. on August 15, 2025. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Cassius I. O. Chaar, M.D.
- Inspection Date: 2025-08-15
- Product Type: other
- Office Name: New England District Office
- Summary: An FDA inspection of Cassius I. O. Chaar, M.D., a clinical investigator in New Haven, CT, revealed a significant issue with the timely reporting of Serious Adverse Events (SAEs). The firm failed to report 33.3% of SAEs within the protocol-mandated 10 days of awareness, with some delays extending over 900 days. This indicates a failure to adhere to investigational plan requirements.

## Related Officers

- [Meredith L. Miller](https://www.globalkeysolutions.net/people/meredith-l-miller/c775003b-4e5b-48d8-bc51-1a3ebe813dba)

Company: https://www.globalkeysolutions.net/companies/cassius-i-o-chaar-md/94cb1f93-f16e-4327-ae9c-abfdeb45a459

Office: https://www.globalkeysolutions.net/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144